Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2007; 13(45): 6115-6118
Published online Dec 7, 2007. doi: 10.3748/wjg.v13.i45.6115
Published online Dec 7, 2007. doi: 10.3748/wjg.v13.i45.6115
Figure 2 Base line FDG PET/CT detecting huge metastases in the right lobe of liver and highly metastatic lymphoid nodes in abdomen (white arrows, A and B), second FDG PET/CT demonstrating huge metastases in the right lobe of liver and the decreased number, size and metabolism level of metastatic lymphoid nodes (white arrows, C and D), third FDG PET/CT displaying the disappeared huge metastases in the right lobe of liver and the normal size of metastatic lymphoid nodes (E and F).
- Citation: Sun L, Ye HY, Zhang YH, Guan YS, Wu H. Epidermal growth factor receptor antibody plus recombinant human endostatin in treatment of hepatic metastases after remnant gastric cancer resection. World J Gastroenterol 2007; 13(45): 6115-6118
- URL: https://www.wjgnet.com/1007-9327/full/v13/i45/6115.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i45.6115